Back to CHARLES SCHWAB INVESTMENT MANAGEMENT INC CHARLES SCHWAB INVESTMENT MANAGEMENT INC

NRIXNRIX
Showing 8 of 24 quarters

Position history for CHARLES SCHWAB INVESTMENT MANAGEMENT INCCHARLES SCHWAB INVESTMENT MANAGEMENT INC's holdings in NURIX THERAPEUTICS INC

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds 833,296 shares of NRIX (NURIX THERAPEUTICS INC), worth $20.2M as of 2026-Q2. The position was decreased (-9.8% shares). NRIX represents 0.0% of CHARLES SCHWAB INVESTMENT MANAGEMENT INC's portfolio.

Current Value

$20.2M

Current Shares

833,296

Total Value Change

+$8.7M

Total Shares Change

+321,576

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
833,296
-9.8%
$20.2M0.0%$24.26
0
2026-Q1
Decreased
924,039
-4.3%
$14.3M0.0%$15.81
0
2025-Q4
Increased
965,892
+11.7%
$18.3M0.0%$19.02
32
2025-Q3
Increased
864,380
+42.4%
$8M0.0%$9.28
37
2025-Q2
Increased
607,127
+4.3%
$6.9M0.0%$11.64
28
2025-Q1
Increased
582,066
+1.6%
$6.9M0.0%$12.15
28
2024-Q4
Increased
572,834
+11.9%
$10.8M0.0%$18.64
31
2024-Q3
Decreased
511,720
-17.9%
$11.5M0.0%$23.05
0

Other major holders of NRIX: BlackRock, Inc., FMR LLC, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used